Takyar M - Search Results

1

Antibody-mediated Rejection of Kidney Allografts Following COVID-19: A Report of Two Cases.

Fazeli SA, Takyar M, Parvin M, Haririan A, Alirezaei A. Fazeli SA, et al. Among authors: takyar m. Iran J Kidney Dis. 2022 Nov;16(6):330-336. Iran J Kidney Dis. 2022. PMID: 36454029

2

Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment.

Azizi F, Takyar M, Madreseh E, Amouzegar A. Azizi F, et al. Among authors: takyar m. Thyroid. 2019 May;29(5):625-630. doi: 10.1089/thy.2018.0397. Epub 2019 Apr 23. Thyroid. 2019. PMID: 30803411 Clinical Trial.

3

Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial.

Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M. Azizi F, et al. Among authors: takyar m. Thyroid. 2019 Sep;29(9):1192-1200. doi: 10.1089/thy.2019.0180. Epub 2019 Aug 28. Thyroid. 2019. PMID: 31310160 Clinical Trial.

4

Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter.

Azizi F, Saadat N, Takyar MA, Abdi H, Mehran L, Amouzegar A. Azizi F, et al. Among authors: takyar ma. Endocrinol Metab (Seoul). 2022 Dec;37(6):861-869. doi: 10.3803/EnM.2022.1476. Epub 2022 Nov 23. Endocrinol Metab (Seoul). 2022. PMID: 36415961 Free PMC article. Clinical Trial.

5

Tehran Thyroid Study (TTS).

Amouzegar A, Mehran L, Takyar M, Abdi H, Azizi F. Amouzegar A, et al. Among authors: takyar m. Int J Endocrinol Metab. 2018 Oct 24;16(4 Suppl):e84727. doi: 10.5812/ijem.84727. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584429 Free PMC article. Review.

6

Contributions and Implications of the Tehran Lipid and Glucose Study.

Azizi F, Takyar M, Zadeh-Vakili A. Azizi F, et al. Among authors: takyar m. Int J Endocrinol Metab. 2018 Oct 31;16(4 Suppl):e84792. doi: 10.5812/ijem.84792. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584448 Free PMC article. Review.

7

Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a risk-scoring model.

Azizi F, Amouzegar A, Khalili D, Abdi H, Tohidi M, Hedayati M, Cheraghi L, Mehrabi Y, Takyar M. Azizi F, et al. Among authors: takyar m. Endocrine. 2024 May;84(2):577-588. doi: 10.1007/s12020-023-03656-5. Epub 2024 Jan 2. Endocrine. 2024. PMID: 38165576 Clinical Trial.

8

Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study.

Azizi F, Zadeh-Vakili A, Takyar M. Azizi F, et al. Among authors: takyar m. Int J Endocrinol Metab. 2018 Oct 22;16(4 Suppl):e84777. doi: 10.5812/ijem.84777. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584442 Free PMC article. Review.

9

TPO antibody in euthyroid pregnant women and cognitive ability in the offspring: a focused review.

Amouzegar A, Pearce EN, Mehran L, Lazarus J, Takyar M, Azizi F. Amouzegar A, et al. Among authors: takyar m. J Endocrinol Invest. 2022 Feb;45(2):425-431. doi: 10.1007/s40618-021-01664-8. Epub 2021 Sep 13. J Endocrinol Invest. 2022. PMID: 34515961 Review.

10

Parity and Incidence of Thyroid Autoimmunity: A Population-Based Tehran Thyroid Study.

Takyar M, Rahmani M, Amouzegar A, Madreseh E, Tohidi M, Mehran L, Azizi F. Takyar M, et al. Thyroid. 2020 Aug;30(8):1186-1192. doi: 10.1089/thy.2019.0440. Epub 2020 May 7. Thyroid. 2020. PMID: 32159458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters